Why Badger Meter Stock Is Sinking Again Today

Badger Meter reported full-year revenue, EPS, and free cash flow growth of 11%, 13%, and 19% respectively for 2025, but Q4 sales of $221 million missed expectations by $11 million, rising 8% year-over-year and only 2% organically. Operational positives include margin improvement, Smart Cover sales up 25% (acquired 2025), SaaS revenue growth of 27% making up nearly 10% of total sales, and the company securing its largest-ever contract (Puerto Rico project) that begins in 2026. CEO Kenneth Bockhorst said base revenue growth was compressed by concluding AMI turnkey projects in H2 2025 and expects improvement as multi-year deployments ramp in H2 2026; the shares sold off ~10% intraday and are down ~30% over the past year, while valuation has moved from a five-year average of 43x FCF to roughly 26x FCF.

Analysis

Market structure: Badger Meter (BMI) is transitioning from hardware to higher-margin software/AMI turnkey solutions; winners include BMI, SaaS vendors and large utilities that capture operational savings from AMI, while low-tech mechanical meter suppliers face margin pressure. The Puerto Rico award concentrates near-term revenue timing risk but creates a multi-year installation backlog that should restore demand in H2 2026–2028, shifting pricing power toward turnkey integrators with proven delivery. Cross-asset effects are modest but visible: BMI volatility should stay elevated (options IV up near events), selective muni issuance could rise to finance utility capex (supportive for muni credit activity), and commodity impact (copper/plastics) is incremental not systemic.

Risk assessment: Tail risks include project cancellation/delay (Puerto Rico political/financial risk), failed Smart Cover integration, and utility rate-disallowance for AMI cost recovery; any of these could cut revenue by >10–20% over 12 months. Time horizons: expect immediate price volatility (days), depressed base revenue through H1 2026 per management, and potential inflection H2 2026+ as awarded projects convert; hidden dependencies are customer financing/rate approvals and concentration (one very large deal). Key catalysts are Q1 2026 guidance (within ~60–90 days), start of Puerto Rico deployments (calendar 2026), and SaaS ARR reaching 12–15% of sales.

Trade implications: Direct play — consider initiating a 2–3% portfolio long in BMI now, scaling in on weakness (add if price drops another 15%), target a 12–24 month return of 40–60% if FCF growth sustains ~10% and multiple re-rates toward 35x. Pair trade — long BMI vs short ITRI (Itron) 1:1 to isolate AMI SaaS exposure (BMI has faster SaaS ramp; ITRI remains more legacy-hardware sensitive). Options — buy Jan 2027 LEAPS calls or a 2:1 long-LEAP to short-monthly-call structure to finance premium; alternatively, use a collar with a -25% downside stop to limit loss.

Contrarian angles: The market likely overreacted to a timing miss — BMI trades ~26x FCF vs 43x five-year average while FCF grew 19% in 2025; if SaaS grows to >12% by end-2026 and backlog converts, upside is underpriced. Consensus misses concentration and regulatory execution risk but also underestimates recurring revenue margin expansion; comparable historical re-ratings occurred when industrials shifted to services (e.g., EMR-like transitions). Monitor three KPIs weekly/monthly — awarded-but-not-yet-recognized backlog, SaaS ARR growth rate, and gross-margin expansion of >200bp — and tighten/exit positions if backlog conversion rate falls below 50% over two consecutive quarters.

Key Decisions for Investors

• Establish a 2–3% long position in BMI now; plan to add equal-sized tranches if the share price falls another 15% (scale-in) and set a hard stop-loss at -25% from initial entry to control single-name risk.
• Enter a pair trade: long BMI (2% portfolio) vs short ITRI (Itron) equal notional (2%) to express conviction in BMI's SaaS-led margin story while hedging AMI-cycle risk; rebalance after Q1 2026 guidance release (within ~90 days).
• If volatility is elevated, buy Jan 2027 BMI LEAPS (net exposure ~2% portfolio) financed by selling 1–3 month OTM calls (covered if long stock) or construct a 2027 collar protecting downside below -25%; close or reprice after Puerto Rico deployment starts (target H2 2026).
• Reduce exposure to legacy mechanical meter names and allocate +2% to utility-tech/SaaS names with visible ARR growth; monitor BMI KPIs (backlog conversion >50%, SaaS share >12% by Q4 2026, gross margin +200bp) — if met, increase BMI position to 4–5% over 12–24 months.